Skip to main content

Advertisement

Log in

Variations in Surgical Treatment and Outcomes of Patients With Pancreatic Cancer: A Population-Based Study

  • Hepatobiliary and Pancreatic Tumors
  • Original Paper
  • Published:
Annals of Surgical Oncology Aims and scope Submit manuscript

Abstract

Background

There is ongoing debate on how variations in surgical technique affect outcomes in pancreatic cancer. This population-based study examines current surgical practice and outcomes for cancer of the pancreatic head.

Methods

All patients 18 to 85 years old diagnosed with nonmetastatic adenocarcinoma of the pancreatic head from 1998 through 2003 were identified from the Surveillance, Epidemiology and End Results (SEER) Program registry. Multivariable regression was used to elucidate factors associated with the type of pancreaticoduodenectomy performed, extent of lymph node (LN) assessment, early mortality, and late survival.

Results

Overall, 2111 patients were included in the study, with 83.7% treated with a standard Whipple pancreaticoduodenectomy (PD). However, there was marked regional variation in the use of pylorus-preserving pancreaticoduodenectomy (PPPD; range, .03%–32.0%; P < .0001) and total pancreatectomy (TP; range, .04%–19.5%; P < .0001). TP was associated with significantly higher early mortality (odds ratio, 2.6; 95% confidence interval, 1.6 to 4.1; P < .0001), but late survival did not differ significantly between TP, PPPD, and PD (P = .69). Significant variation was also seen in the number of LN assessed (range across SEER regions, 7.3–13.5; P < .0001). Decreased LN assessment reduced the odds of diagnosing a patient as node positive and was associated with worse late survival.

Conclusions

In this population-based study, we found marked clinically important variability in the surgical treatment of adenocarcinoma of the pancreatic head, with respect to the use of TP, PPPD, or PD, and the extent of LN assessment. Further research is warranted to elucidate the underlying reasons, and to clarify the role of adequate lymphadenectomy.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

FIG. 1.
FIG. 2.
FIG. 3.
FIG. 4.

Similar content being viewed by others

References

  1. Jemal A, Siegel R, Ward E, et al. Cancer statistics, 2006. CA Cancer J Clin 2006;56:106–30

    Article  PubMed  Google Scholar 

  2. Stojadinovic A, Brooks A, Hoos A, Jaques DP, Conlon KC, Brennan MF. An evidence-based approach to the surgical management of resectable pancreatic adenocarcinoma. J Am Coll Surg 2003;196:954–64

    Article  PubMed  Google Scholar 

  3. Kausch W. Das carcinom der papilla duodeni und seine radikale entfernung. Beitr Klin Chir 1912;78:439–51

    Google Scholar 

  4. Whipple AO. Present-day surgery of the pancreas. N Engl J Med 1942;226:515–8

    Article  Google Scholar 

  5. Watson K. Carcinoma of the ampulla of Vater. Successful radical resection. Br J Surg 1944;31:368–73

    Article  Google Scholar 

  6. Bell RH Jr. Pancreaticoduodenectomy with or without pylorus preservation have similar outcomes. Cancer Treat Rev 2005;31:328–31

    Article  PubMed  Google Scholar 

  7. Hunt DR, McLean R. Pylorus-preserving pancreatectomy: functional results. Br J Surg 1989;76:173–6

    Article  PubMed  CAS  Google Scholar 

  8. Lin PW, Lin YJ. Prospective randomized comparison between pylorus-preserving and standard pancreaticoduodenectomy. Br J Surg 1999;86:603–7

    Article  PubMed  CAS  Google Scholar 

  9. Lin PW, Shan YS, Lin YJ, Hung CJ. Pancreaticoduodenectomy for pancreatic head cancer: PPPD versus Whipple procedure. Hepatogastroenterology 2005;52:1601–4

    PubMed  Google Scholar 

  10. Nguyen TC, Sohn TA, Cameron JL, et al. Standard vs radical pancreaticoduodenectomy for periampullary adenocarcinoma: a prospective, randomized trial evaluating quality of life in pancreaticoduodenectomy survivors. J Gastrointest Surg 2003;7:1–9

    Article  PubMed  Google Scholar 

  11. Riall TS, Cameron JL, Lillemoe KD, et al. Pancreaticoduodenectomy with or without distal gastrectomy and extended retroperitoneal lymphadenectomy for periampullary adenocarcinoma—part 3: update on 5-year survival. J Gastrointest Surg 2005;9:1191–204

    Article  PubMed  Google Scholar 

  12. Seiler CA, Wagner M, Bachmann T, et al. Randomized clinical trial of pylorus-preserving duodenopancreatectomy versus classical Whipple resection-long term results. Br J Surg 2005;92:547–56

    Article  PubMed  CAS  Google Scholar 

  13. Seiler CA, Wagner M, Sadowski C, Kulli C, Buchler MW. Randomized prospective trial of pylorus-preserving vs classic duodenopancreatectomy (Whipple procedure): initial clinical results. J Gastrointest Surg 2000;4:443–52

    Article  PubMed  CAS  Google Scholar 

  14. Shan YS, Sy ED, Lin PW. Role of somatostatin in the prevention of pancreatic stump-related morbidity following elective pancreaticoduodenectomy in high-risk patients and elimination of surgeon-related factors: prospective, randomized, controlled trial. World J Surg 2003;27:709–14

    Article  PubMed  Google Scholar 

  15. van Berge Henegouwen MI, Moojen TM, van Gulik TM, Rauws EA, Obertop H, Gouma DJ. Postoperative weight gain after standard Whipple’s procedure versus pylorus-preserving pancreatoduodenectomy: the influence of tumour status. Br J Surg 1998;85:922–6

    Article  PubMed  Google Scholar 

  16. van Berge Henegouwen MI, van Gulik TM, DeWit LT, et al. Delayed gastric emptying after standard pancreaticoduodenectomy versus pylorus-preserving pancreaticoduodenectomy: an analysis of 200 consecutive patients. J Am Coll Surg 1997;185:373–9

    PubMed  Google Scholar 

  17. Wagner M, Redaelli C, Lietz M, Seiler CA, Friess H, Buchler MW. Curative resection is the single most important factor determining outcome in patients with pancreatic adenocarcinoma. Br J Surg 2004;91:586–94

    Article  PubMed  CAS  Google Scholar 

  18. Yeo CJ, Cameron JL, Lillemoe KD, et al. Pancreaticoduodenectomy with or without distal gastrectomy and extended retroperitoneal lymphadenectomy for periampullary adenocarcinoma, part 2: randomized controlled trial evaluating survival, morbidity, and mortality. Ann Surg 2002;236:355–66

    Article  PubMed  Google Scholar 

  19. Yeo CJ, Cameron JL, Sohn TA, et al. Pancreaticoduodenectomy with or without extended retroperitoneal lymphadenectomy for periampullary adenocarcinoma: comparison of morbidity and mortality and short-term outcome. Ann Surg 1999;229:613–22

    Article  PubMed  CAS  Google Scholar 

  20. Tran KT, Smeenk HG, van Eijck CH, et al. Pylorus preserving pancreaticoduodenectomy versus standard Whipple procedure: a prospective, randomized, multicenter analysis of 170 patients with pancreatic and periampullary tumors. Ann Surg 2004;240:738–45

    Article  PubMed  Google Scholar 

  21. Farnell MB, Pearson RK, Sarr MG, et al. A prospective randomized trial comparing standard pancreatoduodenectomy with pancreatoduodenectomy with extended lymphadenectomy in resectable pancreatic head adenocarcinoma. Surgery 2005;138:618–28

    Article  PubMed  Google Scholar 

  22. Pedrazzoli S, DiCarlo V, Dionigi R, et al. Standard versus extended lymphadenectomy associated with pancreatoduodenectomy in the surgical treatment of adenocarcinoma of the head of the pancreas: a multicenter, prospective, randomized study. Lymphadenectomy Study Group. Ann Surg 1998;228:508–17

    CAS  Google Scholar 

  23. Hirata K, Sato T, Mukaiya M, et al. Results of 1001 pancreatic resections for invasive ductal adenocarcinoma of the pancreas. Arch Surg 1997;132:771–6

    PubMed  CAS  Google Scholar 

  24. Satake K, Nishiwaki H, Yokomatsu H, et al. Surgical curability and prognosis for standard versus extended resection for T1 carcinoma of the pancreas. Surg Gynecol Obstet 1992;175:259–65

    PubMed  CAS  Google Scholar 

  25. Takahashi S, Ogata Y, Miyazaki H, et al. Aggressive surgery for pancreatic duct cell cancer: feasibility, validity, limitations. World J Surg 1995;19:653–9

    Article  PubMed  CAS  Google Scholar 

  26. Schwarz RE, Smith DD. Extent of lymph node retrieval and pancreatic cancer survival: information from a large US population database. Ann Surg Oncol 2006;13:1189–200

    Article  PubMed  Google Scholar 

  27. Surveillance, Epidemiology and End Results (SEER) Program. Public-use data (1973–2003). National Cancer Institute, DCCPS, Surveillance Research Program, Cancer Statistics Branch, released April 2006, based on the November 2005 submission. Available at: http://www.seer.cancer.gov. Accessed July 31, 2006

  28. Zippin C, Lum D, Hankey BF. Completeness of hospital cancer case reporting from the SEER Program of the National Cancer Institute. Cancer 1995;76:2343–50

    Article  PubMed  CAS  Google Scholar 

  29. Warren JL, Klabunde CN, Schrag D, Bach PB, Riley GF. Overview of the SEER-Medicare data: content, research applications, and generalizability to the United States elderly population. Med Care 2002;40:IV-3–18

    Google Scholar 

  30. Surveillance, Epidemiology and End Results (SEER). About SEER—data access and quality. National Cancer Institute. Available at: http://www.seer.cancer.gov/about/uses.html. Accessed January 4, 2006

  31. Havener L. Standards for Cancer Registries, Volume III: Standards for completeness, Quality, Analysis and Management of Data. Springfield, IL: North American Association of Central Cancer Registries, 2004

  32. SEER—Extent of disease, 1988: codes and coding instructions. National Cancer Institute. Available at: http://www.seer.cancer.gov/publicdata/documentation.html. Accessed July 23, 2005

  33. Diehr P, Cain K, Connell F, Volinn E. What is too much variation? The null hypothesis in small-area analysis. Health Serv Res 1990;24:741–71

    PubMed  CAS  Google Scholar 

  34. Hosmer JW, Lemeshow S. Applied Logistic Regression. New York: John Wiley & Sons, 1989

    Google Scholar 

  35. Cleveland WS. Robust locally weighted regression and smoothing scatterplots. J Am Stat Assoc J 1979;74:829–36

    Article  Google Scholar 

  36. Birkmeyer JD, Sun Y, Wong SL, Stukel TA. Hospital volume and late survival after cancer surgery. Ann Surg 2007;245:777–83

    Article  PubMed  Google Scholar 

  37. Birkmeyer JD, Warshaw AL, Finlayson SR, Grove MR, Tosteson AN. Relationship between hospital volume and late survival after pancreaticoduodenectomy. Surgery 1999;126:178–83

    PubMed  CAS  Google Scholar 

  38. Rogers SO Jr, Wolf RE, Zaslavsky AM, Wright WE, Ayanian JZ. Relation of surgeon and hospital volume to processes and outcomes of colorectal cancer surgery. Ann Surg 2006;244:1003–11

    Article  PubMed  Google Scholar 

  39. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. Am Stat Assoc J 1958;53:457–81

    Article  Google Scholar 

  40. Cox DR. Regression models and life tables. J R Stat Assoc B 1972;29:187–220

    Google Scholar 

  41. Diener MK, Knaebel HP, Heukaufer C, Antes G, Buchler MW, Seiler CM. A systematic review and meta-analysis of pylorus-preserving versus classical pancreaticoduodenectomy for surgical treatment of periampullary and pancreatic carcinoma. Ann Surg 2007;245:187–200

    Article  PubMed  Google Scholar 

  42. Patterns of Health Care in Ontario: The ICES Practice Atlas. 2nd edition. Ottawa: Canadian Medical Association, 1996

    Google Scholar 

  43. McPherson K, Wennberg JE, Hovind OB, Clifford P. Small-area variations in the use of common surgical procedures: an international comparison of New England, England, and Norway. N Engl J Med 1982;307:1310–4

    Article  PubMed  CAS  Google Scholar 

  44. Karanicolas PJ, Davies E, Kunz R, et al. The pylorus: take it or leave it? systematic review and meta-analysis of pylorus-preserving versus standard Whipple pancreaticoduodenectomy for pancreatic or periampullary cancer. Ann Surg Oncol 2007

  45. Karpoff HM, Klimstra DS, Brennan MF, Conlon KC. Results of total pancreatectomy for adenocarcinoma of the pancreas. Arch Surg 2001;136:44–7

    Article  PubMed  CAS  Google Scholar 

  46. Ihse I, Anderson H, Andren S. Total pancreatectomy for cancer of the pancreas: is it appropriate? World J Surg 1996;20:288–93

    Article  PubMed  CAS  Google Scholar 

  47. Assan R, Alexandre JH, Tiengo A, Marre M, Costamailleres L, Lhomme C. Survival and rehabilitation after total pancreatectomy. A follow-up of 36 patients. Diabet Metab 1985;11:303–9

    CAS  Google Scholar 

  48. Dresler CM, Fortner JG, McDermott K, Bajorunas DR. Metabolic consequences of (regional) total pancreatectomy. Ann Surg 1991;214:131–40

    Article  PubMed  CAS  Google Scholar 

  49. Allema JH, Reinders ME, van Gulik TM, et al. Prognostic factors for survival after pancreaticoduodenectomy for patients with carcinoma of the pancreatic head region. Cancer 1995;75:2069–76

    Article  PubMed  CAS  Google Scholar 

  50. Lim JE, Chien MW, Earle CC. Prognostic factors following curative resection for pancreatic adenocarcinoma: a population-based, linked database analysis of 396 patients. Ann Surg 2003;237:74–85

    Article  PubMed  Google Scholar 

  51. Neoptolemos JP, Dunn JA, Stocken DD, et al. Adjuvant chemoradiotherapy and chemotherapy in resectable pancreatic cancer: a randomised controlled trial. Lancet 2001;358:1576–85

    Article  PubMed  CAS  Google Scholar 

  52. Ricciardi R, Baxter NN. Association versus causation versus quality improvement: setting benchmarks for lymph node evaluation in colon cancer. J Natl Cancer Inst 2007;99:414–5

    Article  PubMed  Google Scholar 

  53. Cooper GS, Virnig B, Klabunde CN, Schussler N, Freeman J, Warren JL. Use of SEER-Medicare data for measuring cancer surgery. Med Care 2002;40:IV-43–8

    Article  Google Scholar 

Download references

Acknowledgments

A.G. is supported by the National Cancer Institute of Canada/Canadian Cancer Society Clinical Research Fellowship. N.N.B. is supported by an American Society of Clinical Oncology Career Development Award. C.H.L.L. is a career scientist of the Ontario Ministry of Health and Long-Term Care and is supported through a Health Research Personnel Development—Career Scientist Award.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Calvin H. L. Law MD, MPH.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Govindarajan, A., Tan, J.C.C., Baxter, N.N. et al. Variations in Surgical Treatment and Outcomes of Patients With Pancreatic Cancer: A Population-Based Study. Ann Surg Oncol 15, 175–185 (2008). https://doi.org/10.1245/s10434-007-9601-7

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1245/s10434-007-9601-7

Keywords

Navigation